Aberrant production of leukotriene C4 by macrophages from autoimmune- prone mice by unknown
ABERRANT PRODUCTION OF LEUKOTRIENE C4 BY
MACROPHAGES FROM AUTOIMMUNE-PRONE MICE
By THOMAS J. SANTORO, DAN H. MORRIS, ROBERT C. MURPHY,
AND RODNEY C. BAKER
From the Departments of Medicine and Pharmacology, University of Colorado Health Sciences Center;
and the Denver Veterans Administration Medical Center, Denver, Colorado 80262
Eicosanoidshave been implicated in the pathogenesis ofautoimmunediseases such
as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The evi-
dence linking eicosanoids and rheumatic diseases is primarily based upon the con-
ceptthat several eicosanoids thatare potent mediators ofinflammation canalsomodify
immune function and that SLE and RA are inflammatory diseases associated with
altered immune responses. The specific contribution any individual lipoxygenase
or cyclooxygenase product has in predisposing to lupus remains to be established.
Although prostaglandins (PGs) may promoteinflammation by virtue oftheircapacity
to induce edema, erythema, andhyperalgesia (1), certainprostanoidsappear to protect
against the development ofautoimmune disease. Parenteral administration ofprosta-
glandin Et (PGE,) prevents the expression oflupus in autoimmune-prone New Zea-
land (2)and MRL-lpr/lpr (3) mice. Incontrast, leukotrienes (LT) mayhave apermis-
siveeffect onthe developmentofautoimmunity (reviewed inreference 4). Oxygenation
ofarachidonic acid by a 5-lipoxygenase yields 5-hydroperoxyeicosatetraenoic acid,
which can be further metabolized to leukotriene A4 (LTA4). In murine peritoneal
macrophages (M0), stimulation with zymosan preferentially converts LTA4 into the
sulfidopeptide LTC4 (5). Peptidolysis ofLTC4 sequentially produces LTD4 and LTE4,
which collectivelycomprise the slowreacting substance ofanaphylaxis(SRS-A). The
SRS-A are bronchoconstrictors, stimulate mucous production in the trachea, in-
crease vascular permeability, and induce the releaseoflysosomalenzymes (reviewed
in reference 6). More recently, LTC4, and/or its metabolites, have been reported
to exert potent effects on the murine system, inducing the synthesis of IFN-'Y (7)
and inhibiting the proliferation of T cells (8).
Leukotriene synthesis in the setting ofautoimmunity has not been previously in-
vestigated andisthe focus ofthis study. Micethat spontaneouslymanifestlupus-like
illnesses were chosen as the experimental model (reviewed in references 9, 10).
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Mice.
￿
Mice werepurchasedfromtheJackson Laboratory, Bar Harbor, ME. MRL-lpr/lpr,
MRL-+/+,andC57BL/6-lpr/lprmice were bredin the Animal Research Facility at the Denver
This work was supported by grants from the Veterans Administration, the Rocky Mountain Chapter
oftheArthritisFoundation, andtheNational Institutes ofHealth (AI-26284, HL-25785, andAA-07157).
T.J. Santorois arecipient ofaFIRSTAwardfrom theNational Institutes ofHealth. Addresscorrespon-
dence to T. J. Santoro, Rheumatology Section (IIIG), Veterans Administration Medical Center, 1055
Clermont Street, Denver, CO 80220.
J. Exp. MED. C The Rockefeller University Press - 0022-1007/88/08/0783/06 $2.00
￿
783784
￿
SANTORO ET AL.
￿
BRIEF DEFINITIVE REPORT
Veterans Administration Medical Center. MRL-lpr/lpr mice exhibit an accelerated and se-
vere disease that has features of both SLE and RA (10). Congenic MRL- +/+ mice, which
lack the lpr gene but possess an autoimmune background (9, 10), and C57BL/6-lpr/lpr mice,
which possess the lpr gene on a nonautoimmune background, both develop an indolent type
of lupus without an arthritic component.
In Vitro Culture.
￿
2 x 105 resident peritoneal M0 were dispensed in 96-well flat-bottomed
plates (Costar, Cambridge, MA) in Eagle's Basal Medium (BME) (Gibco Laboratories Cha-
grin Falls, OH) plus 10% FCS and incubated at 37°C in a humidifiedatmosphere containing
5% C02 for 2 h. The cells were then washed and cultured for 2-24 h in BME with 0-150
wg/ml zymosan (Sigma Chemical Co., St. Louis, MO). The supernatants were harvested
and analyzed freshly for eicosanoid activity using enzyme immunoassays (11) with tracers
purchased from AIA, Inc. (Aurora, CO) or dialyzed and examined for IL-1 activity, as previ-
ously described (12). After adherence, 80-92% of cells were M0 as evaluated by nonspecific
esterase staining. There were no significant differences in the percentage of M0 obtained
from autoimmune vs. normal mice. In experiments using HPLC, 106 Mo were dispensed
in 35-mm petri dishes in 2 ml BME and cultured for 2 h with 150 Rg/ml of zymosan at 37°C
in 5% C02 .
HPLCAnalyses.
￿
Supernatants from freshly prepared samples were spiked with [3H]LTC4
(New England Nuclear, Boston, MA) (16,000 dpm, 120 pg) and [3H]LTD4 (15,000 dpm, 90
pg) to determine recovery and with PGB2 (Cayman Chemicals, Ann Arbor, MI) (500 ng)
to provide a reference point for chromatographic analysis. HPLC analysis was performed
usinga liquid chromatograph (model 1090; Hewlett-Packard Co., Palo Alto, CA). The gra-
dient was run at a flowrate of 1 ml/min with the initial mobile phase being methanol/water/phos-
phoric acid (30:70:0.02, vol/vol, pH 5.7, with ammonium hydroxide) for 6 min, followed by
a linear gradient to 100% methanol over 44 min. The overall recovery of radioactivity was
81 ± 3% for [3H]LTC4 and 74 t 3% for [3H]LTD4 in these samples.
Results
The profile of lipoxygenase metabolites produced by zymosan-stimulated perito-
neal Mo from 16-wk-old autoimmune-prone and immunologically normal mice was
initially investigated using reverse-phase HPLC and a gradient-mobile phase. The
chromatogram obtained in zymosan-induced M0 from normal C57BL/6 +/+ mice
(Fig. 1 A) shows a peak that elutes with a retention time identical to that ofauthentic
LTC4 (Fig. 1, peak 1) and with a UV spectrum (Fig. 1, insert) characteristic of a leu-
kotriene. Further analysis ofthis peak by enzyme immunoassay (EIA) (Fig. 1 A histo-
gram) confirmed the presence of LTC4. The second peak represents the 11-trans
isomer of LTC4 (Fig. 1 A). PGB2, the internal standard (peak 3) elutes at 30.3 min.
LTB4 was not detectable in the M0 supernatants. Similar profiles were observed in
zymosan-activated Mo from autoimmune C57BL/6-lpr/lpr, MRL- +/+, and MRL-
lpr/lpr mice (Fig. 1, B-D, respectively) and from immunologically normal C3H/HeN
mice (data not shown). Thus, Mm obtained from autoimmune and normal mice
demonstrate qualitatively comparable lipoxygenase products on stimulation with
zymosan, and in all cases the predominant leukotriene synthesized is LTC4.
The capacity of Mo from autoimmune-prone MRL mice and immunologically
normal C3H/HeN mice of various ages to produce LTC4 was next investigated by
directly measuring eicosanoid activity in the supernatants of zymosan-induced cul-
tures using EIA. An age-associated increase in the ability of MRL-lpr/lpr Mo to pro-
duce LTC4 in response to zymosan was observed (Fig. 2). In Mm from MRL- +/+
mice, no such enhancement was seen (Fig. 2), and, in response to zymosan, M0
from the latter strain produced levels of LTC4 that were comparable with those from
C3H/HeN mice (not shown). Zymosan stimulation of M0 from 6- and 20-wk-oldQ
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autoimmune C57BL/6-1pr/lpr mice produced levels of LTC4 that were equivalent
to those generated by Mo from age-matched control C57BL/6- +/+ and BALB/c
mice (data not shown).
It remained possible that increased LTC4 production by Mo from MRL-1pr/1pr
mice was the consequence ofenhanced responsiveness to zymosan. This was inves-
tigated by optimally stimulating Mo (106/ml) from young (3-5 wk) and old (12-
20 wk) MRL mice with zymosan (150 ug/ml) for 24 h, then testing the dialyzed
FIGURE 2.
￿
Age-associated changes in
zymosan-stimulated LTC4 produc-
tion. Peritoneal M0 from young (3-
5wk) andold(12-20 wk) MRL- +/+
(open squares), MRL-lpr/lpr (closed
squares), and C3H/HeN (not shown)
mice were stimulated with up to 150
ug/mlofzymosan. Supernatants were
harvested after a 2-h culture and as-
sayedforLTC4 by EIA. Values repre-
sent the mean t SE of three experi-
ments. (`)p < 0.05 usinga nonpaired
ttest. The dose response curves forM0
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supernatants for IL-1 activity. Comparable levels of IL-1 were produced by Mo from
MRL- +/+ mice (74 t 5 U/ml) and MRL-Ipr/lpr mice (80 ± 6 U/ml) at all ages
tested. Similar results were obtained when both the total time of culture and the
dose of zymosan were varied (data not shown).
In contrast to those from normal mice, a significant increase in spontaneous LTC4
production was observed in MW from MRL-lpr/lpr mice. A systematic survey of
various autoimmune-prone strains revealed high spontaneous production of LTC4
to be a common feature of Mo from mice that manifested lupus-like illnesses
(Fig. 3) . The augmented spontaneous LTC4 activity was found to increase further
with age and was unrelated to either gender (not shown) or to MHC haplotype.
Spontaneous LTC4 release was most marked in M0 from MRL-lpr/lpr mice (Fig. 3).
Measurements of PGE2 in MIA cultures from 4- (not shown) and 16- (Fig. 3)
wk-old autoimmune mice for up to 24 h revealed no differences in the spontaneous
release of prostanoids relative to normal mice.
Discussion
The results presentedherein demonstrate that M0 from autoimmune-prone mice
exhibit a novel aberration in arachidonic acid metabolism, producing levels of LTC4
that were up to 10 times greater than those from age-, sex-, and MHC-matched
immunologically normal mice in the absence of deliberate addition of exogenous
stimulants . Levels of LTC4 comparable with those spontaneously released by Mo
from MRL-Ipr/lpr mice 8 wk of age or older (N10-$ M) have been shown in vitro
to (a) stimulate DNA synthesis in human epidermal keratinocytes (13) ; (b) augment
the proliferation of human cultured fibroblasts (14); (c) induce the mitogenesis of
human glomerular epithelial cells (15); and (d) replace the helper cell requirement
for immune IFN production by murine T cells (7). The age-associated increase in
spontaneous LTC4 production was independent of sex and was shared by Mo from
MHC disparate autoimmune mice with distinct patterns of disease. The data sug-
gest that augmented spontaneous LTC4 release may be a common feature of mu-
Strain Haplotype Age
(H-2) (wk)
C3H/HeN k 4-20
18
+MRL-+/+ k
tMRL-Ipr/Ipr k
4-6
B-12
20
16
4-8L
B-12
20
16
C57BL/6-+/. b 4-20
16
4-6
+C57BL/6-_Ipr/_Ipr b
￿
6-10
16
BALE/c d 4-20
10
1]LTC4
PGE2
FIGURE 3.
￿
Spontaneous eicosanoid production
by Mm from normal and autoimmune (+)
murine strains at different ages. Supernatants
from peritoneal M0 were cultured for 2 h or
24 h and assayed freshlyforLTC4 (open bars) and
PGE2 (hatchedbars), respectively, by EIA. Results
represent the mean t SE of 3-5 experiments.
Spontaneous LTC4 release was significantlyen-
hanced (p < 0.05) in M0 from 20-wk-old MRL-
+/+ mice, 8- andZO-wk-oldMRL-1pr/lpr mice,
and 10-wk-old C57BL/6-1pr/1pr mice relative to
that from the respective control by anon-paired
Student's t test.SANTORO ET AL.
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rine lupus. That Mo from certain strains (e.g., MRL- +/+ ) display enhanced
spontaneous production of LTC4 at a time when no overt manifestations of autoim-
munity are present indicates that this aberration may be of etiopathogenetic
significance. Mo from MRL-lpr/lpr mice, which manifest the most aggressive lupus-
like illness of all strains tested, possessed the greatest capacity to produce LTC4 both
spontaneously and in response to zymosan stimulation. The relationship between
disease severity and augmented LTC4 production further indicates that the two
phenomena may be pathogenetically linked. The mechanism by which spontaneous
production of LTC4 may predispose to the development of autoimmune disease is
a matter of speculation. However, by increasing vascular permeability and inducing
the release of lysosomal enzymes (4, 5), LTC4 could contribute to the inflamma-
tio.i and tissue destruction characteristically seen in lupus.
Summary
Eicosanoids have been implicated in the pathogenesis of autoimmune diseases.
In this study, peritoneal macrophages from autoimmune-prone mice were exam-
ined for their capacity to produce proinflammatory 5-lipoxygenase metabolites. The
results indicate that enhanced production of leukotriene C4 is a common feature
of murine autoimmunity and suggest further that aberrations in 5-lipoxygenase ac-
tivity may play a role in the development of lupus.
Receivedfor publication 1 March 1988 and in revisedform 16 May 1988.
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